Eur Rev Med Pharmacol Sci 2021; 25 (23): 7192-7192
DOI: 10.26355/eurrev_202112_27408

MiR-524 inhibits cell proliferation and induces cell apoptosis in thyroid cancer via targeting SPAG9

Z. Zhen, F. Dong, H. Shen, Q.-G. Wang, L. Yang, J. Hu

Department of Otolaryngology, Head and Neck Surgery, Peking University First Hospital, Beijing, China.

 

The article “MiR-524 inhibits cell proliferation and induces cell apoptosis in thyroid cancer via targeting SPAG9”, by Z. Zhen, F. Dong, H. Shen, Q.-G. Wang, L. Yang, J. Hu, published in Eur Rev Med Pharmacol Sci 2018; 22 (12): 3812-3818–DOI: 10.26355/eurrev_201806_15265–PMID: 29949157, has been retracted by the authors due to some unrepeated data in their current research.

The Publisher apologizes for any inconvenience this may cause.

MiR-524 inhibits cell proliferation and induces cell apoptosis in thyroid cancer via targeting SPAG9

Free PDF Download

To cite this article

Z. Zhen, F. Dong, H. Shen, Q.-G. Wang, L. Yang, J. Hu
MiR-524 inhibits cell proliferation and induces cell apoptosis in thyroid cancer via targeting SPAG9

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 23
Pages: 7192-7192
DOI: 10.26355/eurrev_202112_27408

Keywords Related articles:

  1. MiR-524 inhibits cell proliferation and induces cell apoptosis in thyroid cancer via targeting SPAG9
  2. MiR-431 inhibits cell proliferation and induces cell apoptosis by targeting CDK14 in pancreatic cancer
  3. MiR-499b-5p inhibits cervical cancer cell proliferation and induces apoptosis by targeting the Notch1 signaling pathway
  4. CircPSMC3 inhibits cell proliferation and induces cell apoptosis in nasopharyngeal carcinoma by downregulating ROCK1
  5. Oncogene miR-934 promotes ovarian cancer cell proliferation and inhibits cell apoptosis through targeting BRMS1L